KELLY SOSA: Open Payments
NPI 1891943692 · BYRAM, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 37 payments from 13 companies in 2025. Trend: 2023 $793 · 2024 $592 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $218 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| ABBVIE INC. | 4 | $81 |
| Astellas Pharma US Inc | 3 | $75 |
| Inspire Medical Systems, Inc. | 1 | $68 |
| Lundbeck LLC | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: NURTEC ODT, AIRSUPRA, Veozah, INSPIRE, UBRELVY, REXULTI, Symbravo, VOQUEZNA.
Industry payments across MS — which companies pay providers there.
